By addressing the hormonal and metabolic factors underlying weight gain, micro-dosing offers a targeted solution that complements other lifestyle changes
With no other semaglutide-related patents listed in Canadas Patent Register, the path is now clear for generic and biosimilar competitors to enter the Canadian market as early as January 2026, when regulatory data exclusivity also expires
The secretion of GLP-1 is partly mediated by nutrient binding to G-protein-coupled receptors (GPCRs) or by absorption via membrane transporters, which are expressed by enteroendocrine L cells in the gastrointestinal tract
Gough SC, Bode BW, Woo VC, et al
Nausea becomes more common, particularly in the mornings and after meals containing fat
Our Top 5 Providers, Compared Our highest-scored GLP-1 providers across four categories